DadFinStart your free week
DadFin › Stocks › Healthcare › SRTA

Strata Critical Medical, Inc. (SRTA) stock score

Healthcare · Medical Care Facilities · United States

$4.53 ▲ +1.34% today

48.6
Dad Score, out of 100
middling

Strata Critical Medical, Inc. (SRTA) is a Medical Care Facilities company in the Healthcare sector, listed in the United States. On DadFin's weekly run it scores 48.6 out of 100 on the Dad Score, a middling reading that places the business ahead of 49% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Healthcare it ranks #430 of 974. Its strongest axes are quality, growth and risk; its weakest are price action and liquidity.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Average
Quality
Above average
Growth
Strong
Price action
Below average
Risk
Strong
Conviction
Above average
Liquidity
Below average
Macro
Average

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)0.0×
P/E (forward)0.0×
Dividend yield0.00%
Return on capital13.5%
Operating margin-6.3%
Revenue growth (YoY)+34.3%
FCF yield-15.5%
Net debt / EBITDA-2.56×
Piotroski F-Score4 / 9
52-week change-9.2%
Market cap$418M
Next earningsNov 9, 2026

What subscribers see on SRTA

Start your free weekSubscriber? Open the full research →

Medical Care Facilities peers

StockCompanyDad ScoreBandMarket cap
HCAHCA Healthcare, Inc.94.4strong$94.7B
THCTenet Healthcare Corporation85.2strong$20.8B
FMSFresenius Medical Care AG64.4middling$11.8B
EHCEncompass Health Corporation90.0strong$11.8B
DVADaVita Inc.70.5good$11.5B
UHSUniversal Health Services, Inc.96.7strong$10.4B
ENSGThe Ensign Group, Inc.78.9good$10.0B
PACSPACS Group, Inc.82.5good$6.8B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.